0000950170-24-005896.txt : 20240119
0000950170-24-005896.hdr.sgml : 20240119
20240119192327
ACCESSION NUMBER: 0000950170-24-005896
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240111
FILED AS OF DATE: 20240119
DATE AS OF CHANGE: 20240119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BCLS II Equity Opportunities, LP
CENTRAL INDEX KEY: 0001814474
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38360
FILM NUMBER: 24546796
BUSINESS ADDRESS:
STREET 1: 200 CLARENDON
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6175162000
MAIL ADDRESS:
STREET 1: 200 CLARENDON
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BCLS II Equity Opportunities GP, LLC
CENTRAL INDEX KEY: 0002008174
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38360
FILM NUMBER: 24546797
BUSINESS ADDRESS:
STREET 1: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6175162000
MAIL ADDRESS:
STREET 1: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Solid Biosciences Inc.
CENTRAL INDEX KEY: 0001707502
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 900943402
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 RUTHERFORD AVENUE
STREET 2: 3RD FLOOR
CITY: CHARLESTOWN
STATE: MA
ZIP: 02129
BUSINESS PHONE: 617-337-4680
MAIL ADDRESS:
STREET 1: 500 RUTHERFORD AVENUE
STREET 2: 3RD FLOOR
CITY: CHARLESTOWN
STATE: MA
ZIP: 02129
FORMER COMPANY:
FORMER CONFORMED NAME: Solid Biosciences, LLC
DATE OF NAME CHANGE: 20170524
3
1
ownership.xml
3
X0206
3
2024-01-11
0
0001707502
Solid Biosciences Inc.
SLDB
0002008174
BCLS II Equity Opportunities GP, LLC
200 CLARENDON STREET
BOSTON
MA
02116
true
false
true
false
0001814474
BCLS II Equity Opportunities, LP
200 CLARENDON STREET
BOSTON
MA
02116
true
false
true
false
Common Stock
904160
I
See footnotes
Represents 904,160 shares of Common Stock purchased by BCLS II Equity Opportunities, LP ("BCLS II Equity") directly from the Issuer in a private placement that closed on January 11, 2024.
BCLS II Equity Opportunities GP, LLC ("BCLS II Equity GP") is the general partner of BCLS II Equity. As a result, BCLS II Equity GP may be deemed to share voting and dispositive power with respect to the securities held by BCLS II Equity. BCLS II Equity GP disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
BCLS II EQUITY OPPORTUNITIES GP, LLC, By: Bain Capital Life Sciences Investors, LLC, its ultimate manager, By: /s/ Adam Koppel, Title: Partner
2024-01-19
BCLS II EQUITY OPPORTUNITIES, LP By: Bain Capital Life Sciences Investors, LLC, its ultimate manager, By: /s/ Adam Koppel, Title: Partner
2024-01-19